Live from the NIH registry
Studies recruiting near Winter Haven right now
Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: NRG Oncology
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Ilumina Medical Research — Kissimmee, Florida (26.7 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Florida Retina Consultants - Lakeland /ID# 275012 — Lakeland, Florida (15.3 mi)
· Sponsor: AbbVie
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma
Phase 1, Phase 2
Interventional 768 participants sought
Helios CR Inc — Lakeland, Florida (15.3 mi)
· Sponsor: Boehringer Ingelheim
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Lakeland, Florida (15.3 mi)
· Sponsor: AstraZeneca
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Radiology and Imaging Specialists — Lakeland, Florida (15.3 mi)
· Sponsor: Penumbra Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: Amgen
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Clinical Research of Center Florida — Lakeland, Florida (15.3 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Clinical Research Specialists LLC — Kissimmee, Florida (26.7 mi)
· Sponsor: Pfizer
TNF-α Treatment of Blast-Induced Tinnitus
Tinnitus, Noise Induced
Phase 2
Interventional 88 participants sought
Advent Health — Celebration, Florida (24.0 mi)
· Sponsor: Wayne State University
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
AdventHealth Celebration — Celebration, Florida (24.0 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Kissimmee — Kissimmee, Florida (26.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
AdventHealth Celebration — Celebration, Florida (24.0 mi)
· Sponsor: HistoSonics, Inc.
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3
Interventional 300 participants sought
Alloy Clinical Research LLC — Kissimmee, Florida (26.7 mi)
· Sponsor: Viatris Innovation GmbH
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 72 participants sought
AdventHealth Medical Group Oncology Research at Celebration — Kissimmee, Florida (26.7 mi)
· Sponsor: OncoC4, Inc.
SMP-3124LP in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 120 participants sought
Advent Health — Celebration, Florida (24.0 mi)
· Sponsor: Sumitomo Pharma America, Inc.
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 525 participants sought
Adventhealth — Celebration, Florida (24.0 mi)
· Sponsor: BeOne Medicines
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
The Oncology Institute — Lakeland, Florida (15.3 mi)
· Sponsor: Jazz Pharmaceuticals
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 1
Interventional 1,394 participants sought
Exelixis Clinical Site #48 — Celebration, Florida (24.0 mi)
· Sponsor: Exelixis
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Kissimmee, Florida (26.7 mi)
· Sponsor: GlaxoSmithKline
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Type II Diabetes Mellitus
Phase 2
Interventional 285 participants sought
Alliance for Multispecialty Research (AMR Clinical) - Wichita East — Lakeland, Florida (15.3 mi)
· Sponsor: Sun Pharmaceutical Industries Limited
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Attention Deficit Disorder With Hyperactivity (ADHD)
Phase 2
Interventional 312 participants sought
Alkermes Investigational Site — Lakeland, Florida (15.3 mi)
· Sponsor: Alkermes, Inc.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Auzmer Research /ID# 239251 — Lakeland, Florida (15.3 mi)
· Sponsor: AbbVie
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Clinical Research of Osceola, LLC — Kissimmee, Florida (26.7 mi)
· Sponsor: Hoffmann-La Roche